0.5354
price up icon0.68%   0.0036
after-market アフターアワーズ: .54 0.0046 +0.86%
loading
前日終値:
$0.5318
開ける:
$0.53
24時間の取引高:
112.61K
Relative Volume:
0.28
時価総額:
$19.57M
収益:
$3.04M
当期純損益:
$-33.97M
株価収益率:
-0.4026
EPS:
-1.33
ネットキャッシュフロー:
$-52.47M
1週間 パフォーマンス:
+3.56%
1か月 パフォーマンス:
-3.44%
6か月 パフォーマンス:
-64.89%
1年 パフォーマンス:
-85.76%
1日の値動き範囲:
Value
$0.5242
$0.555
1週間の範囲:
Value
$0.5038
$0.5978
52週間の値動き範囲:
Value
$0.4619
$4.19

Rani Therapeutics Holdings Inc Stock (RANI) Company Profile

Name
名前
Rani Therapeutics Holdings Inc
Name
セクター
Healthcare (1160)
Name
電話
(408) 457-3700
Name
住所
2051 RINGWOOD AVENUE, SAN JOSE
Name
職員
106
Name
Twitter
Name
次回の収益日
2025-03-31
Name
最新のSEC提出書
Name
RANI's Discussions on Twitter

RANI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RANI
Rani Therapeutics Holdings Inc
0.5354 19.57M 3.04M -33.97M -52.47M -1.33
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-08-02 開始されました Oppenheimer Outperform
2024-06-14 開始されました Maxim Group Buy
2024-06-13 開始されました Rodman & Renshaw Buy
2023-04-17 再開されました BTIG Research Buy
2022-10-11 開始されました UBS Buy
2022-07-27 開始されました H.C. Wainwright Buy
2022-06-13 開始されました Wedbush Outperform
すべてを表示

Rani Therapeutics Holdings Inc (RANI) 最新ニュース

pulisher
Jun 11, 2025

291,381 Shares in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Purchased by Two Sigma Investments LP - Defense World

Jun 11, 2025
pulisher
Jun 08, 2025

110,163 Shares in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Purchased by Two Sigma Advisers LP - Defense World

Jun 08, 2025
pulisher
May 30, 2025

Rani Therapeutics announces annual meeting results By Investing.com - Investing.com India

May 30, 2025
pulisher
May 29, 2025

Rani Therapeutics announces annual meeting results - Investing.com

May 29, 2025
pulisher
May 29, 2025

Rani Therapeutics Approves Key Proposals at Annual Meeting - TipRanks

May 29, 2025
pulisher
May 25, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $9.40 Consensus PT from Brokerages - Defense World

May 25, 2025
pulisher
May 23, 2025

What is Zacks Small Cap’s Estimate for RANI Q3 Earnings? - Defense World

May 23, 2025
pulisher
May 22, 2025

Q2 Earnings Estimate for RANI Issued By Zacks Small Cap - Defense World

May 22, 2025
pulisher
May 21, 2025

Rani Therapeutics (NASDAQ:RANI) Stock Price Up 7% – Here’s What Happened - Defense World

May 21, 2025
pulisher
May 20, 2025

Rani Therapeutics Secures $4.3M via Series D Warrant - TipRanks

May 20, 2025
pulisher
May 20, 2025

Rani Therapeutics strikes deal to issue new warrants - Investing.com

May 20, 2025
pulisher
May 20, 2025

Rani Therapeutics strikes deal to issue new warrants By Investing.com - Investing.com Nigeria

May 20, 2025
pulisher
May 20, 2025

Rani Therapeutics Announces Research Agreement with Chugai - GlobeNewswire

May 20, 2025
pulisher
May 19, 2025

Rani Therapeutics explores oral delivery of Chugai’s drugs - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

RANI: 1Q:25 Financial Results - MSN

May 19, 2025
pulisher
May 19, 2025

Rani Therapeutics (RANI) Partners with Chugai for Innovative Research | RANI Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Rani Therapeutics explores oral delivery of Chugai’s drugs By Investing.com - Investing.com India

May 19, 2025
pulisher
May 19, 2025

Rani Therapeutics Enters Research Agreement with Chugai Pharmaceutical to Explore Oral Delivery Technology for Antibody Development - Nasdaq

May 19, 2025
pulisher
May 19, 2025

Breakthrough: Rani's Oral Biologics Platform Matches Injectable Drugs in Chugai Partnership Study - Stock Titan

May 19, 2025
pulisher
May 18, 2025

Oppenheimer Has Lowered Expectations for Rani Therapeutics (NASDAQ:RANI) Stock Price - Defense World

May 18, 2025
pulisher
May 16, 2025

RANI Stock Update: Analyst Maintains Rating, Lowers Price Target | RANI Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Oppenheimer cuts Rani Therapeutics target to $4, keeps Outperform - Investing.com Australia

May 16, 2025
pulisher
May 16, 2025

Oppenheimer cuts Rani Therapeutics target to $4, keeps Outperform By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Oppenheimer Adjusts Rani Therapeutics Price Target to $4 From $14, Maintains Outperform Rating - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

Oppenheimer Adjusts Rani Therapeutics (RANI) Price Target | RANI Stock News - GuruFocus

May 16, 2025
pulisher
May 15, 2025

Rani Therapeutics Highlights Promising Preclinical Data - TipRanks

May 15, 2025
pulisher
May 13, 2025

Rani Therapeutics Q1 2025 Earnings: EPS Misses at -$0.22, Revenue Surpasses Estimates at $0.2 Million - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

Rani Therapeutics Q1 Net Income USD -12.738 Million - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Rani Therapeutics Holdings, Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

Rani Therapeutics Achieves Major Milestone: Oral Obesity Drug Shows Equal Success to Injections in Latest Data - Stock Titan

May 13, 2025
pulisher
May 08, 2025

Ratio Analysis: Unpacking Rani Therapeutics Holdings Inc (RANI)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

May 08, 2025
pulisher
May 07, 2025

Rani Therapeutics faces Nasdaq delisting over market value By Investing.com - Investing.com India

May 07, 2025
pulisher
May 06, 2025

Rani Therapeutics faces Nasdaq delisting over market value - Investing.com

May 06, 2025
pulisher
May 06, 2025

Rani Therapeutics Faces Nasdaq Compliance Challenge - TipRanks

May 06, 2025
pulisher
May 05, 2025

Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update - ADVFN

May 05, 2025
pulisher
May 03, 2025

Rani Therapeutics (RANI) Expected to Announce Quarterly Earnings on Monday - Defense World

May 03, 2025
pulisher
Apr 30, 2025

Rani Therapeutics Board Restructures After DeBuono’s Retirement - TipRanks

Apr 30, 2025
pulisher
Apr 28, 2025

Ratio Examination: Rani Therapeutics Holdings Inc (RANI)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Daily Progress: XPLR Infrastructure LP (XIFR) Drop -1.51, Closing at 8.46 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Market Recap: PowerFleet Inc (AIOT)’s Negative Momentum, Closing at 5.12 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Market Highlights: Clear Channel Outdoor Holdings Inc (CCO) Ends on a Low Note at 1.02 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Post-Trade Analysis: Baytex Energy Corp (BTE) Climbs 0.61, Closing at 1.65 - DWinneX

Apr 28, 2025

Rani Therapeutics Holdings Inc (RANI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Rani Therapeutics Holdings Inc (RANI) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Imran Talat
Chief Executive Officer
Dec 09 '24
Buy
1.94
10,296
19,974
494,751
South Cone Investments Limited
10% Owner
Oct 15 '24
Sale
2.65
3,829,360
10,141,674
8,302,194
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
大文字化:     |  ボリューム (24 時間):